Nervgen Pharma Corp Stock Market Value
| NGEN Stock | CAD 2.90 0.10 3.33% |
| Symbol | NervGen |
NervGen Pharma Corp Price To Book Ratio
NervGen Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NervGen Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NervGen Pharma.
| 01/03/2023 |
| 12/23/2024 |
If you would invest 0.00 in NervGen Pharma on January 3, 2023 and sell it all today you would earn a total of 0.00 from holding NervGen Pharma Corp or generate 0.0% return on investment in NervGen Pharma over 720 days. NervGen Pharma is related to or competes with Aptose Biosciences, IShares Canadian, Altagas Cum, European Residential, RBC Discount, and IShares SPTSX. NervGen Pharma Corp., a regenerative medicine company, engages in the discovery, development, and commercialization of t... More
NervGen Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NervGen Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NervGen Pharma Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.03 | |||
| Information Ratio | 0.0477 | |||
| Maximum Drawdown | 32.94 | |||
| Value At Risk | (7.17) | |||
| Potential Upside | 7.18 |
NervGen Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NervGen Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NervGen Pharma's standard deviation. In reality, there are many statistical measures that can use NervGen Pharma historical prices to predict the future NervGen Pharma's volatility.| Risk Adjusted Performance | 0.0508 | |||
| Jensen Alpha | 0.2872 | |||
| Total Risk Alpha | 0.1385 | |||
| Sortino Ratio | 0.0559 | |||
| Treynor Ratio | 0.4118 |
NervGen Pharma Corp Backtested Returns
NervGen Pharma appears to be dangerous, given 3 months investment horizon. NervGen Pharma Corp has Sharpe Ratio of 0.0711, which conveys that the firm had a 0.0711% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for NervGen Pharma, which you can use to evaluate the volatility of the firm. Please exercise NervGen Pharma's Risk Adjusted Performance of 0.0508, mean deviation of 3.84, and Downside Deviation of 5.03 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, NervGen Pharma holds a performance score of 5. The company secures a Beta (Market Risk) of 0.74, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, NervGen Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding NervGen Pharma is expected to be smaller as well. Please check NervGen Pharma's sortino ratio, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to make a quick decision on whether NervGen Pharma's current price movements will revert.
Auto-correlation | 0.38 |
Below average predictability
NervGen Pharma Corp has below average predictability. Overlapping area represents the amount of predictability between NervGen Pharma time series from 3rd of January 2023 to 29th of December 2023 and 29th of December 2023 to 23rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NervGen Pharma Corp price movement. The serial correlation of 0.38 indicates that just about 38.0% of current NervGen Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.38 | |
| Spearman Rank Test | 0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.16 |
NervGen Pharma Corp lagged returns against current returns
Autocorrelation, which is NervGen Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting NervGen Pharma's stock expected returns. We can calculate the autocorrelation of NervGen Pharma returns to help us make a trade decision. For example, suppose you find that NervGen Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
NervGen Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If NervGen Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if NervGen Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in NervGen Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
NervGen Pharma Lagged Returns
When evaluating NervGen Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of NervGen Pharma stock have on its future price. NervGen Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, NervGen Pharma autocorrelation shows the relationship between NervGen Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in NervGen Pharma Corp.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NervGen Stock Analysis
When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.